Products
Dorlimomab Aritox Biosimilar Antibody-Toxin Conjugate for Research
Cat No.: GMP-Bios-INN-805
Pre-made Dorlimomab Aritox benchmark antibody (ADC, anti-40S ribosomal protein S18 therapeutic antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Order Information
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. →
| Catalog No. | Package | Price(In USD) |
|---|---|---|
| GMP-Bios-INN-805-1mg | 1mg | |
| GMP-Bios-INN-805-10mg | 10mg | |
| GMP-Bios-INN-805-100mg | 100mg | |
| GMP-Bios-INN-805-xmg | ≥100mg |
Product Details
| Products Name (INN Index) | Pre-Made Dorlimomab Aritox Biosimilar, Whole Mab Adc: Anti-40S Ribosomal Protein S18 therapeutic antibody |
| INN Name | Dorlimomab Aritox |
| Target | 40S ribosomal protein S18 |
| Format | ADC |
| Derivation | Mus musculus |
| Species Reactivity | human |
| CH1 Isotype | F(ab')2 - nd - nd |
| VD LC | F(ab')2 - nd - nd |
| Highest_Clin_Trial (Jan '20) | |
| Est. Status | |
| 100% SI Structure | |
| 99% SI Structure | |
| 95-98% SI Structure | |
| Year Proposed | |
| Year Recommended | |
| Companies | Medarex (Princeton NJ USA) / Houston Biotechnology (The Woodlands TX USA) |
| Conditions Approved | |
| Conditions Active | |
| Conditions Discontinued | |
| Development Tech | 0 |
